DelMar Pharmaceuticals, Inc.

VANCOUVER, British Columbia and MENLO PARK, Calif., May 16, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar Pharma") is pleased to provide the following update from President & CEO, Mr. Jeffrey Bacha: During the past quarter, we continued to advance our lead product candidate VAL-083 in an ongoing brain cancer ... read more

VANCOUVER, British Columbia and MENLO PARK, Calif., April 10, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) today announced additional positive interim data from an ongoing Phase I/II clinical trial of VAL-083 in patients with recurrent glioblastoma multiforme (GBM) or progressive secondary brain tumor. The data ... read more

VANCOUVER, British Columbia and MENLO PARK, Calif., April 1, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced that the company would present an abstract entitled "A Phase I/II study of VAL-083 in patients with recurrent malignant glioma or secondary brain tumor" at the American ... read more

VANCOUVER, British Columbia and MENLO PARK, Calif., March 13, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced that the Company has been named to Rocket Builder's 11(th) annual "Ready to Rocket" list. Rocket Builders "Ready to Rocket" list recognizes British Columbia technology companies that are ... read more

VANCOUVER, British Columbia and MENLO PARK, Calif., March 7, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced the completion of a $10.5 million private placement. Charles Vista, LLC acted as the company's placement agent in the unit offering. Each unit consists of one share ... read more

VANCOUVER, British Columbia and MENLO PARK, Calif., Feb. 28, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") is pleased to announce the appointment of Mr. John K. Bell to the company's Board of Directors. John K. Bell, is Chairman of Onbelay Capital Inc., a Canadian based private equity ... read more

VANCOUVER, British Columbia and MENLO PARK, Calif., Feb. 25, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced the fourth closing in a private placement consisting of approximately 2.0 million units of its securities to qualified accredited investors, for gross proceeds of approximately $1.6 million. The ... read more

VANCOUVER, British Columbia and MENLO PARK, Calif., Feb. 11, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced the third closing in a private placement consisting of approximately 1.2 million units of its securities to qualified accredited investors, for gross proceeds of approximately $1.0 ... read more

VANCOUVER, British Columbia and MENLO PARK, Calif., Jan. 31, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced the second closing in a private placement consisting of approximately 1.9 million units of its securities to qualified accredited investors, for gross proceeds of approximately $1.5 ... read more